Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
titin | 0.470 | 0.885 | 2.6E-96 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
ALMS1 centrosome and basal body associated protein | 0.559 | 0.808 | 4.5E-60 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
vacuolar protein sorting 13 homolog B | 0.579 | 0.769 | 2.5E-45 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
adhesion G protein-coupled receptor V1 | 0.572 | 0.731 | 3.2E-39 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
coiled-coil domain containing 141 | 0.666 | 0.538 | 1.6E-33 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
SLX4 structure-specific endonuclease subunit | 0.565 | 0.731 | 1.6E-22 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
cullin 7 | 0.633 | 0.500 | 2.6E-21 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
protein tyrosine phosphatase receptor type Q | 0.751 | 0.462 | 4.2E-21 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
collagen type VI alpha 3 chain | 0.563 | 0.769 | 1.8E-20 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
heparan sulfate proteoglycan 2 | 0.438 | 0.885 | 1.0E-19 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
sodium voltage-gated channel alpha subunit 9 | 0.543 | 0.615 | 4.8E-19 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
phosphomannomutase 2 | 0.535 | 0.769 | 1.4E-17 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
tachykinin receptor 3 | 0.553 | 0.769 | 1.8E-17 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
adaptor related protein complex 4 subunit mu 1 | 0.638 | 0.500 | 4.5E-17 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase 10 | 0.650 | 0.577 | 1.2E-16 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
phenotype | 0.100 | None | 0 | 0 |